← SynDRA
ROCURONIUM
SynDRA canonical compound SYN0023493 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CHRNA2 |
|---|
| Mechanism of action | Acetylcholine receptor antagonist |
|---|
| Indication | anesthetic |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- CHRNA2
- CHRNA1
- CHRNB1
- CHRND
- CHRNG
- ACHE
- CHRM2
- HTR3A
Mechanisms of action (all sources)
- Acetylcholine receptor antagonist
- CHRNA1 ANTAGONIST
- CHRNG ANTAGONIST
- CHRNB1 ANTAGONIST
- CHRND ANTAGONIST
- ACHE ANTAGONIST
- CHRNA2 ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- KCNH2
- ESR1
- AGTR1
- ADORA1
- OPRD1
- HTR2C
- MAOA
- MC3R
- MC4R
- MLNR
- MRGPRX2
- NPY1R
- NR1I2
- NR3C1
- OPRK1
- HTR2A
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC22A1
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- SLCO1A2
- HTR2B
- HRH3
- HTR1A
- ADORA2A
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AVPR1A
- AVPR2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Neuromuscular Agents
- Neuromuscular Blocking Agents
- Neuromuscular Nondepolarizing Agents
- Peripheral Nervous System Agents
- Nondepolarizing Neuromuscular Blocker
ATC classes
- M03A · MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Cross-references
Synonyms
- ROCURONIUM BROMIDE
- ZEMURON
- ORG 9426
- rocuronium bromide
- zemuron
- esmeron
- Rocuronium cation
- Rocuronium ion
- Esmeron (TN)
- Zemuron (TN)
- rocuronium-bromide
- WRE554RFEZ
- CHEBI:8884
- Esmerone
- RefChem:56463
- DTXCID1028314
- Zemuron
- UNII-WRE554RFEZ
- NCGC00167433-01
- RBr
- ROCURONIUM [MI]
- Epitope ID:174837
- C07556
- ROCURONIUM [WHO-DD]
- SCHEMBL29958
- BIDD:GT0360
- GTPL4003
- orb1708656
- TQP0579
- YXRDKMPIGHSVRX-OOJCLDBCSA-N
- HMS2090E03
- BDBM50248153
- AKOS040736692
- CS-0733
- NCGC00167433-04
- NCGC00167433-05
- DA-67272
- HY-17033
Reported adverse events
Look up ROCURONIUM in the interactive SynDRA portal →